GlassScriptPhysician profile
Tabassum Taqi
NPI 1164787255
$5,496.16
in general payments reported to CMS, 2019-2025
38 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $468 · 2021: $768 · 2022: $1,165 · 2023: $1,309 · 2024: $978 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,772.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $968.09 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $956.98 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $612.61 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Lilly USA, LLC | $416.01 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $394.55 | 2021-2025 | |
| Glaxosmithkline, LLC. | $360.13 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astellas Pharma US INC | $208.71 | 2019-2025 | Veozah |
| Pfizer INC. | $173.65 | 2019-2025 | |
| Amarin Pharma, INC. | $163.74 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $156.65 | 2020-2024 | Xifaxan |
| Inspire Medical Systems, INC. | $140.16 | 2023-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.98 | 2019-2025 | Jardiance |
| Abbott Laboratories | $91.24 | 2023-2025 | Freestyle Libre 3 |
| Amgen INC. | $90.14 | 2020-2025 | Repatha, Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $87.13 | 2021-2023 | Trintellix |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $66.18 | 2019-2025 | Gardasil 9, Capvaxive |
| Biohaven Pharmaceuticals, INC. | $53.80 | 2021 | |
| Exact Sciences Corporation | $51.36 | 2025 | Cologuard Collection Kit |
| Antares Pharma, INC. | $35.89 | 2021-2022 | |
| Sanofi Pasteur INC. | $28.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $28.36 | 2020 | |
| Dexcom, INC. | $23.80 | 2023 | Dexcom G6 Transmitter |
| Eisai INC. | $22.88 | 2021 | |
| Daiichi Sankyo INC. | $22.11 | 2020 | |
| Jazz Pharmaceuticals INC. | $21.98 | 2020 | |
| Intuity Medical INC | $21.64 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ethicon US, LLC | $21.54 | 2020 | |
| Dynavax Technologies Corporation | $18.82 | 2019 | |
| Verity Pharmaceuticals INC. | $18.44 | 2025 | Tlando |
| Ibsa Pharma INC. | $17.14 | 2025 | Tirosint, Flector, Licart |
| Allergan, INC. | $16.75 | 2020 | |
| Cook Medical LLC | $16.70 | 2025 | Zilver Ptx |
| Corium, LLC | $14.44 | 2022 | |
| Avanir Pharmaceuticals, INC. | $14.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.00 | 2022 | |
| Sumitomo Pharma America, INC. | $13.70 | 2024 | Gemtesa |
| Mylan Specialty L.P. | $13.43 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabassum Taqi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.